LAMASSU BIO INC
Transformational therapies for serious unmet medical needs
Durham, United States · Founded 2023
- Headquarters
- Durham, North Carolina
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- lamassubiotech.com
About
Lamassu Biotech is a clinical-stage biopharmaceutical company developing transformational therapies for serious unmet medical needs. Its pipeline includes RABI-767, a novel therapeutic for severe acute pancreatitis, and SA53, an MDM2 inhibitor molecular targeted therapy for cancer. The company uses innovative drug development processes to accelerate the path from discovery to clinical application.
Summary
LAMASSU BIO INC is a Biotech company based in Durham, United States, founded in 2023.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lamassu-bio-inc"><img src="https://indexed.vc/api/badge/company/lamassu-bio-inc" alt="LAMASSU BIO INC on Indexed.vc" width="260" height="76" /></a>